AU2001236919A1 - Premeiotic and postmeiotic origin of teratomas: isolated teratoma stem cells for therapeutic uses - Google Patents

Premeiotic and postmeiotic origin of teratomas: isolated teratoma stem cells for therapeutic uses

Info

Publication number
AU2001236919A1
AU2001236919A1 AU2001236919A AU3691901A AU2001236919A1 AU 2001236919 A1 AU2001236919 A1 AU 2001236919A1 AU 2001236919 A AU2001236919 A AU 2001236919A AU 3691901 A AU3691901 A AU 3691901A AU 2001236919 A1 AU2001236919 A1 AU 2001236919A1
Authority
AU
Australia
Prior art keywords
premeiotic
postmeiotic
teratomas
origin
isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001236919A
Inventor
Irina A Lubensky
Edward Oldfield
Alexander Vortmeyer
Zhengping Zhuang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2001236919A1 publication Critical patent/AU2001236919A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001236919A 2000-02-09 2001-02-09 Premeiotic and postmeiotic origin of teratomas: isolated teratoma stem cells for therapeutic uses Abandoned AU2001236919A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18130900P 2000-02-09 2000-02-09
US60181309 2000-02-09
PCT/US2001/004456 WO2001059076A2 (en) 2000-02-09 2001-02-09 Premeiotic and postmeiotic origin of teratomas: isolated teratoma stem cells for therapeutic uses

Publications (1)

Publication Number Publication Date
AU2001236919A1 true AU2001236919A1 (en) 2001-08-20

Family

ID=22663739

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001236919A Abandoned AU2001236919A1 (en) 2000-02-09 2001-02-09 Premeiotic and postmeiotic origin of teratomas: isolated teratoma stem cells for therapeutic uses

Country Status (2)

Country Link
AU (1) AU2001236919A1 (en)
WO (1) WO2001059076A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024873A1 (en) * 2000-09-20 2002-03-28 Christopher Ralph Franks Stem cell therapy
EP1395652A2 (en) * 2000-11-30 2004-03-10 Stemron, Inc. Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
WO2004018652A2 (en) * 2002-08-16 2004-03-04 Ulrich Drews Method for obtaining diploid, pluripotential stem cells and use thereof
FR2852957B1 (en) 2003-03-31 2005-06-10 Sod Conseils Rech Applic NOVEL IMIDAZO-PYRIDINE DERIVATIVES AND THEIR USE AS A MEDICINAL PRODUCT
WO2020010249A1 (en) * 2018-07-06 2020-01-09 The Regents Of The University Of California Novel method to engineer translantable human tissues
JP2023516484A (en) 2020-03-11 2023-04-19 ビット バイオ リミテッド Hepatocyte production method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432711B1 (en) * 1993-11-03 2002-08-13 Diacrin, Inc. Embryonic stem cells capable of differentiating into desired cell lines
GB9517779D0 (en) * 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
DE19653685B4 (en) * 1996-12-13 2006-06-01 Institut für Pflanzengenetik und Kulturpflanzenforschung In vitro vascular smooth muscle cell system for pharmacological and physiological examinations
WO1998057538A1 (en) * 1997-06-18 1998-12-23 The Curators Of The University Of Missouri Complete activation of mammalian oocytes
AU783162B2 (en) * 1999-09-07 2005-09-29 Advanced Cell Technology, Inc. Method for generating immune-compatible cells and tissues using nuclear transfer techniques

Also Published As

Publication number Publication date
WO2001059076A2 (en) 2001-08-16
WO2001059076A3 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
AU2003239159A1 (en) Placental derived stem cells and uses thereof
AU7813401A (en) Isolation and use of solid tumor stem cells
AU2001232834A1 (en) Generation of dopaminergic neurons from human nervous system stem cells
AU2001270014A1 (en) Compositions for identification and isolation of stem cells
AU2001283492A1 (en) Methods of patterning protein and cell adhesivity
AU2001259323A1 (en) Derivation of midbrain dopaminergic neurons from embryonic stem cells
AU2002319054A1 (en) Multipotent stem cells from peripheral tissues and uses thereof
HK1081225A1 (en) Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
AU6340600A (en) Telomerase inhibitors and methods of their use
AU2001260847A1 (en) Compositions isolated from skin cells and methods for their use
AU2002306865A1 (en) Generation of multipotent central nervous system stem cells
AU2001290078A1 (en) Stem cell therapy
AU2002348947A1 (en) Compositions and methods for amplification of human stem cells
AUPR074500A0 (en) Treatment of t cell disorders
AU2001236919A1 (en) Premeiotic and postmeiotic origin of teratomas: isolated teratoma stem cells for therapeutic uses
AU2001247880A1 (en) Methods to prepare and use epidermal stem cells
AUPR856501A0 (en) Detection of haematopoietic stem cells and progeny and uses thereof
AU2003299914A1 (en) Isolation and identification of cross-reactive t cells
AU2998300A (en) Genetically altered mesenchymal stem cells and methods of use thereof
AU2001294010A1 (en) Stem cells
AU2002251681A1 (en) Production and use of dopaminergic cells to treat dopaminergic deficiencies
AU2001284380A1 (en) Therapeutic and cosmetic uses of heparanases
AU3594400A (en) Isolation of stem cells and methods of use thereof
AU2001272497A1 (en) Regulation of human mast cell protease 6-like enzyme
AU2001286506A1 (en) Isolated mammalian neural stem cells, methods of making such cells, and methods of using such cells